SCHEMBL22985050

SCHEMBL22985050

N#Cc1cccc(-c2ccc3c(c2)c2cc(-c4cccc(C#N)c4)ccc2n3-c2ccc(-c3ccc(C(F)(F)F)cc3C#N)cc2-c2ccc(C#N)cc2-n2c3ccc(-c4cccc(C#N)c4)cc3c3cc(-c4cccc(C#N)c4)ccc32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39
PTPN5 P54829 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
CETP P11597 1/20 0.37
PDK2 Q15119 1/20 0.36
MAT2A P31153 1/20 0.36
XDH P47989 1/20 0.35
KIF11 P52732 1/20 0.34
GRIN1 Q05586 2/20 0.34
GRIN2B Q13224 2/20 0.34
SCN9A Q15858 1/20 0.34
ENPP1 P22413 1/20 0.33
TRPA1 O75762 1/20 0.33
KDM4E B2RXH2 1/20 0.32
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
HCRTR1 O43613 1/20 0.32
HCRTR2 O43614 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985051 0.96 PTPN5 (0.38) ALOX5APFEN1PTPN5PTGDR2CETP
SCHEMBL22985350 0.96 ALOX5AP (0.39) ALOX5APFEN1PTPN5PTGDR2CETP
SCHEMBL22985273 0.96 ALOX5AP (0.40) ALOX5APFEN1PTPN5PTGDR2CETP
SCHEMBL22985525 0.96 ALOX5AP (0.40) ALOX5APFEN1PTPN5PTGDR2CETP
SCHEMBL22985289 0.94 ALOX5AP (0.39) ALOX5APFEN1PTPN5PTGDR2CETP
SCHEMBL22985367 0.93 ALOX5AP (0.40) ALOX5APFEN1PTPN5PTGDR2CETP
SCHEMBL22985364 0.93 KIF11 (0.42) ALOX5APFEN1PTPN5PTGDR2PDK2
SCHEMBL22985366 0.93 ALOX5AP (0.42) ALOX5APFEN1PTGDR2CETPXDH
SCHEMBL22985709 0.93 AR (0.42) ALOX5APFEN1PTPN5PTGDR2CETP
SCHEMBL22985136 0.93 PTPN5 (0.38) ALOX5APFEN1PTPN5PTGDR2CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 ALOX5AP 2567/4885FEN1 2939/4885PTPN5 4289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.